Development of refractory heart failure treatment in internal medicine
Abstract:Refractory heart failure ( RHF) is a familiar complication of cardiovascular disease in end-stage.And it is unsuccessful to treat RHF by a single medicine .Currently, the efficiency of RHF treatment was improved by combination of convenitional medicines , clinical application of milrinone , recombinant human brain natriuretic peptide and levosimendan .The application of organ support such as blood purification technology , intra-aortic balloon pump , ventricular assist device and extracorporeal membrane oxygenation was benefit to RHF therapy .Recent development of RHF treatment in internal medicine was outlined in this paper .
Keywords:Refractory heart failure ( RHF)Recombinant human brain natriuretic peptide (rh-BNP)LevosimendanBlood purification technologyOrgan support
Publication Date:2014-01-01
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:5( 757-761 )
Chinese Journal of Critical Care Medicine

Chinese Journal of Critical Care Medicine

PKUISTIC
ISSN:1002-1949
Year, Vol.(Issue):2014,(8)